← Eichor
Condition: Symbiotic Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Symbiotic

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial
Phase 1 · 1 location(s) · University of Chicago · NCT06871111Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult
Phase 2 · 12 location(s) · Pfizer · NCT07476287Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota Dysbiosis
EARLY_Phase 1 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT06615986Modulation of Gut Microbiota Composition and Gut Permeability Profiles by Multispecies Synbiotic Supplementation in Hemo
NA · 1 location(s) · Tungs' Taichung Metroharbour Hospital · NCT07461233Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal Flora
Phase N/A · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05153824Nationwide Research on the Rewilding of Kindergarten Yards
NA · 2 location(s) · Natural Resources Institute Finland · NCT06390878Effect of the Administration of a Symbiotic (E. Faecium and Agave Inulin) on Mild Cognitive Impairment in Older Adults
NA · 1 location(s) · Anahuac University · NCT05688618Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer
Phase 1/Phase 2 · 73 location(s) · Pfizer · NCT07227298Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy
NA · 1 location(s) · Federal University of Minas Gerais · NCT06576986Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatmen
Phase 1/Phase 2 · 49 location(s) · Pfizer · NCT07227012Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adu
Phase 3 · 413 location(s) · Pfizer · NCT07222566Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastro
Phase 2/Phase 3 · 69 location(s) · Pfizer · NCT07392892Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adul
Phase 2/Phase 3 · 73 location(s) · Pfizer · NCT07226999Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · 115 location(s) · Pfizer · NCT07421700Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Phase 2 · 3 location(s) · Pfizer · NCT07489066Therapeutic Potential of a Synbiotic to Improve Mental Health in Subjects With Obesity.
NA · 1 location(s) · Celia Bañuls · NCT06901739Alterations of Gut Derived Uremic Toxins and Microbiome Metabolites by Multispecies Synbiotic
NA · 1 location(s) · Tungs' Taichung Metroharbour Hospital · NCT07443280Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Antica
Phase 1/Phase 2 · 128 location(s) · Pfizer · NCT07227415Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis
NA · 2 location(s) · Natural Resources Institute Finland · NCT06390696Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · 285 location(s) · Pfizer · NCT07222800
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.